Wide-Awake Local Anesthesia vs. Regional/General Anesthesia for Flexor Tendon Repair

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Western Ontario, Canada

About this trial

Wide-awake hand surgery with local anesthetic, no tourniquet and no sedation (WALANT) is increasingly utilized. Conventional anesthesia for hand surgery involves a patient with a block, unable to perform motor function in the arm, and with patient either intubated or sedated, unable to follow surgeon instructions intra-operatively. Flexor tendon repair with a wide awake and cooperative patient is routinely performed successfully at some centres. This method provides several potential benefits including being able to have the patient actively flex the digit and visualize the repair site to assess for any tendon gapping at the repair site, ensure adequate approximation, gliding and absence of triggering. There have not been any prospectively collected randomized controlled trials comparing wide awake vs. regional/general anesthesia in flexor tendon repair. The purpose of our study is to assess for differences in early outcomes including stiffness, patient satisfaction and early complications in wide-awake anesthesia when compared to general/regional anesthesia for flexor tendon repair in zones I and II. Our hypothesis is that there is a lower complication rate and better outcomes when using wide-awake flexor tendon repair.

Eligibility criteria

Qualifiers

over the age of 18

acute single or multiple digit complete flexor tendon lacerations in zones I or II presenting to attending physicians who agree to participate in the study.

Disqualifiers

gross wound contamination

segmental tendon loss

associated finger fractures

sub-acute or chronic ruptures (ruptures > 6 weeks old)

Trial design

Treatments tested in this trial

  • WALANT
  • General/regional anesthesia
  • WALANT Injection
  • Regional Anesthetic Injection

Treatment groups

88 Participants
are divided into 2 treatment groups

Locations

This trial has no locations